Indication

Hepatic coma

Hepatic coma represents the most severe, life-threatening stage (Grade IV) of hepatic encephalopathy, characterized by profound central nervous system depression, complete loss of consciousness, and unresponsiveness to external stimuli. Read more about Hepatic coma

15 drugs 14 manufacturers

Advertisement

Drugs that treat it

Common Hepatic coma therapies.

Showing 1–9 of 15 drugs

NEOMYCIN SULFATE

ORAL AMINOGLYCOSIDES·PREOPERATIVE BOWEL PREPARATION·+2
X-GEN PHARMACEU

NEOMYCIN SULFATE

ORAL AMINOGLYCOSIDES·PREOPERATIVE BOWEL PREPARATION·+2
TEVA USA
Filter & compare in the drug finder →Opens the drug finder with Hepatic coma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hepatic coma.

Hepatic coma represents the most severe, life-threatening stage (Grade IV) of hepatic encephalopathy, characterized by profound central nervous system depression, complete loss of consciousness, and unresponsiveness to external stimuli.

This neuropsychiatric complication primarily affects patients with acute liver failure, end-stage chronic liver disease or cirrhosis, or significant portosystemic shunting.

Pathophysiologically, severe hepatic dysfunction and the bypass of portal blood flow permit circulating neurotoxins—predominantly ammonia—to cross the blood-brain barrier.

This neurotoxic accumulation triggers astrocyte swelling, systemic and neuroinflammation, and impaired neurotransmission, which can culminate in cerebral edema, elevated intracranial pressure, and coma.

Personalize your experience

Follow Hepatic coma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it